PIWIL1 |
Lung cancer |
up |
DNA hypomethylation |
[105] |
Gastric cancer |
up |
Regulate signaling pathway of gastric cancer |
[106] |
Colorectal cancer |
up |
be used as an important molecular marker for predicting the prognosis of CRC patients |
[107] |
Renal cell cancer |
down |
serve as potential prognostic biomarkers in patients with RCC |
[103] |
Endometrial cancer |
up |
become a valuable target for developing a novel treatment; DNA methylation |
[108, 109] |
Invasive ductal carcinoma |
up |
aberrant DNA methylation |
[110] |
PIWIL2 |
glioma |
up |
correlated with the poor prognosis |
[111] |
cervical cancer |
up |
induced H3K9 acetylation but reduced H3K9 trimethylation, |
[112] |
Non-small cell lung cancer |
up |
increasing the expression of CDK2 and CyclinA |
[113] |
Renal cell cancer |
down |
connected with bad survival |
[103] |
PIWIL3 |
Glioma |
down |
regulate PIWIL3/piR-30,188/OIP5-AS1/miR-367-3p/CEBPA/TRAF4 pathway |
[38] |
Gastric cancer |
up |
regulate JAK2/STAT3 signaling pathway |
[114] |
Multiple myeloma |
up |
involve in MM progression and metastatic |
[115] |
PIWIL4 |
Triple-negative breast cancer |
up |
activating TGF-β, MAPK/ERK, and FGF signaling and avoiding immune recognition |
[116] |